Skip to main content
. Author manuscript; available in PMC: 2020 Jul 15.
Published in final edited form as: Cancer Res. 2019 May 21;79(14):3776–3788. doi: 10.1158/0008-5472.CAN-18-3652

Table 1.

Growth Rates and progression free survival (PFS) for all patients sorted by PFS. Missing pre-treatment growth rates are due to availability of only one scan pre-treatment. Numbers in brackets reflect the error in the parameter estimate, (−) indicates an uncertainty in volume doubling time (VDT) of < 0.1 day. Note the intervals are asymmetric as the error in the growth rate affects the VDT in a non-linear fashion. The symbols (¶,§,○) mark tumors in the same patient.

Tumor
number
VDTpre [days] VDTpost [days] PFS Tumor
number
VDTpre
[days]
VDTpost [days] PFS
1 61.4 (−) 200.2 (−) 4.2 11 - 344.3 (333.8,355.5) 12.1
2 87.9 (74.8, 107) 37 (34.4, 39.9) 4.3 12 - 132.2 (128.8, 135.7) 12.8
3§ - 103.1 (100.6, 105.8) 4.4 13 - 328.5 (229.8, 576) 13.8
4§ - 85.4 (72.3, 104.3) 4.4 14 - 483.7 (−) 16.8
5 - 36.3 (−) 5.8 15 - 99.6 (92.6, 107.7) 20.3
6 - 82.6 (−) 7.5 16 84.1 (−) 243.5 (−) 22.9
7 96.7 (−) 30.6 (−) 8.6 17 - 355.6 (334.9, 379.1) 25.3
8 35.2 (−) 72.3 (−) 8.6 18 260.5 (−) 327.4 (−) 36.8
9 - 39.9 (39.4,40.3) 9.3 19 45.3 (−) 122.3 (−) 37.3
10 - 209.3 (195.6, 224.9) 12.1 20 35.8 (−) 216.9 (−) 37.3